LPL Financial’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-183,479
Closed -$98.8K 5208
2024
Q4
$98.8K Buy
183,479
+94,623
+106% +$51K ﹤0.01% 4879
2024
Q3
$84.4K Sell
88,856
-110,000
-55% -$105K ﹤0.01% 4819
2024
Q2
$194K Buy
198,856
+90,000
+83% +$87.7K ﹤0.01% 4485
2024
Q1
$172K Buy
+108,856
New +$172K ﹤0.01% 4469